Table of Contents

2019-2024 Global Opioids Drug Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioids Drug Consumption 2014-2024
2.1.2 Opioids Drug Consumption CAGR by Region
2.2 Opioids Drug Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.2.5 Other
2.3 Opioids Drug Consumption by Type
2.3.1 Global Opioids Drug Consumption Market Share by Type (2014-2019)
2.3.2 Global Opioids Drug Revenue and Market Share by Type (2014-2019)
2.3.3 Global Opioids Drug Sale Price by Type (2014-2019)
2.4 Opioids Drug Segment by Application
2.4.1 Pain?Relief
2.4.2 Anesthesia
2.4.3 Other
2.5 Opioids Drug Consumption by Application
2.5.1 Global Opioids Drug Consumption Market Share by Application (2014-2019)
2.5.2 Global Opioids Drug Value and Market Share by Application (2014-2019)
2.5.3 Global Opioids Drug Sale Price by Application (2014-2019)

3 Global Opioids Drug by Players
3.1 Global Opioids Drug Sales Market Share by Players
3.1.1 Global Opioids Drug Sales by Players (2017-2019)
3.1.2 Global Opioids Drug Sales Market Share by Players (2017-2019)
3.2 Global Opioids Drug Revenue Market Share by Players
3.2.1 Global Opioids Drug Revenue by Players (2017-2019)
3.2.2 Global Opioids Drug Revenue Market Share by Players (2017-2019)
3.3 Global Opioids Drug Sale Price by Players
3.4 Global Opioids Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Opioids Drug Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Opioids Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Opioids Drug by Regions
4.1 Opioids Drug by Regions
4.1.1 Global Opioids Drug Consumption by Regions
4.1.2 Global Opioids Drug Value by Regions
4.2 Americas Opioids Drug Consumption Growth
4.3 APAC Opioids Drug Consumption Growth
4.4 Europe Opioids Drug Consumption Growth
4.5 Middle East & Africa Opioids Drug Consumption Growth

5 Americas
5.1 Americas Opioids Drug Consumption by Countries
5.1.1 Americas Opioids Drug Consumption by Countries (2014-2019)
5.1.2 Americas Opioids Drug Value by Countries (2014-2019)
5.2 Americas Opioids Drug Consumption by Type
5.3 Americas Opioids Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Opioids Drug Consumption by Countries
6.1.1 APAC Opioids Drug Consumption by Countries (2014-2019)
6.1.2 APAC Opioids Drug Value by Countries (2014-2019)
6.2 APAC Opioids Drug Consumption by Type
6.3 APAC Opioids Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Opioids Drug by Countries
7.1.1 Europe Opioids Drug Consumption by Countries (2014-2019)
7.1.2 Europe Opioids Drug Value by Countries (2014-2019)
7.2 Europe Opioids Drug Consumption by Type
7.3 Europe Opioids Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Opioids Drug by Countries
8.1.1 Middle East & Africa Opioids Drug Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Opioids Drug Value by Countries (2014-2019)
8.2 Middle East & Africa Opioids Drug Consumption by Type
8.3 Middle East & Africa Opioids Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Opioids Drug Distributors
10.3 Opioids Drug Customer

11 Global Opioids Drug Market Forecast
11.1 Global Opioids Drug Consumption Forecast (2019-2024)
11.2 Global Opioids Drug Forecast by Regions
11.2.1 Global Opioids Drug Forecast by Regions (2019-2024)
11.2.2 Global Opioids Drug Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Opioids Drug Forecast by Type
11.8 Global Opioids Drug Forecast by Application

12 Key Players Analysis
12.1 Purdue Pharma
12.1.1 Company Details
12.1.2 Opioids Drug Product Offered
12.1.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Purdue Pharma News
12.2 J&J
12.2.1 Company Details
12.2.2 Opioids Drug Product Offered
12.2.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 J&J News
12.3 Teva
12.3.1 Company Details
12.3.2 Opioids Drug Product Offered
12.3.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Teva News
12.4 Mylan
12.4.1 Company Details
12.4.2 Opioids Drug Product Offered
12.4.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Mylan News
12.5 Depomed
12.5.1 Company Details
12.5.2 Opioids Drug Product Offered
12.5.3 Depomed Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Depomed News
12.6 INSYS
12.6.1 Company Details
12.6.2 Opioids Drug Product Offered
12.6.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 INSYS News
12.7 Endo
12.7.1 Company Details
12.7.2 Opioids Drug Product Offered
12.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Endo News
12.8 Pfizer
12.8.1 Company Details
12.8.2 Opioids Drug Product Offered
12.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Pfizer News
12.9 Hikma
12.9.1 Company Details
12.9.2 Opioids Drug Product Offered
12.9.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Hikma News
12.10 Mallinckrodt
12.10.1 Company Details
12.10.2 Opioids Drug Product Offered
12.10.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Mallinckrodt News
12.11 Pernix
12.12 Egalet
12.13 Vistapharm

13 Research Findings and Conclusion